Showing results (61-70 of 210) with videos related to
Sort By:
Pageof 21
Clinical and Experimental Rheumatology|April 9, 2014
Periodic fevers in adult Greeks: clinical and molecular presentationTheofilos P Karatsourakis, Katerina N Oikonomaki, Athanasios G Tzioufas, et al.Clinical and Experimental Rheumatology|December 7, 2021
Patient-reported experience and health-related quality of life in patients with primary Sjögren's syndrome in EuropeChiara Seghieri, Enrico Lupi, Athanasios G Tzioufas, et al.Clinical and Experimental Rheumatology|November 18, 2017
Non-invasive vascular biomarkers in patients with Behçet's disease: review of the data and future perspectivesAthanase D Protogerou, Efthimia G Nasothimiou, Petros P Sfikakis, et al.Arthritis and Rheumatism|October 30, 2013
Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcomeAndreas V Goules, Ioanna P Tatouli, Haralampos M Moutsopoulos, et al.Cureus|November 6, 2020
Diagnosis and Management of a Young Girl With Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS) Linked to a Novel MutationEleni Klinaki, Adrianos Nezos, Athanasios G Tzioufas, et al.JAMA|July 29, 2010
Treatment of primary Sjögren syndrome: a systematic reviewManuel Ramos-Casals, Athanasios G Tzioufas, John H Stone, et al.Mediterranean Journal of Rheumatology|May 25, 2022
Kinetics of Mononuclear Cell Subpopulations in the Peripheral Blood of Patients with Giant Cell Arteritis During the Acute Phase of the Disease: The Role of SteroidsOurania D Argyropoulou, Dimitrios Anastasios Palamidas, Nikolaos Paschalidis, et al.The Journal of Rheumatology|October 11, 2002
Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosusJohn P A Ioannidis, Gikas E Katsifis, Athanasios G Tzioufas, et al.Annals of the Rheumatic Diseases|May 21, 2018
Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjögren's syndromeEfstathia K Kapsogeorgou, Aristea Papageorgiou, Athanase D Protogerou, et al.Neurology(R) Neuroimmunology & Neuroinflammation|July 30, 2019
Trial of canakinumab, an IL-1β receptor antagonist, in patients with inclusion body myositisMichalis L Kosmidis, Dimitris Pikazis, Panayotis Vlachoyiannopoulos, et al.Pageof 21